Moyamoya Disease Market Segmentation:
Drug Type Segment Analysis
The calcium channel blocker segment in the moyamoya disease market is anticipated to hold a notable share of about 53% in the moyamoya disease drug market over the forecast period on account of the increasing usage of calcium channel blockers to control and lessen stroke symptoms. Every 40 seconds, a stroke occurs, and every 4 minutes, a stroke-related death occurs. Stroke causes more than 140,000 fatalities annually. According to statistics, women account for 60% of stroke deaths while men account for 40%. In addition, in one patient, the incidence of headaches, seizures, and transient ischemia events decreased, while there were no more incidents in the other patient.
End-User Segment Analysis
The hospitals segment is attributed to hold the largest share of 72% because of the large number of patients, this raises the need for medications in hospitals. In the US, one in a million persons suffer from Moyamoya disease. Children are the disease's primary victims. While adults can also be diagnosed, children are often diagnosed at the age of 7.
Our in-depth analysis of the global market includes the following segments:
|
Drug Type |
|
|
Diagnosis |
|
|
Treatment |
|
|
End-User |
|
